Free EMR Newsletter Want to receive the latest news on EMR, Meaningful Use, ARRA and Healthcare IT sent straight to your email? Join thousands of healthcare pros who subscribe to EMR and HIPAA for FREE!!

Healthcare Content Creation for the Audience Economy – #HITsm Chat Topic

Posted on April 11, 2017 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

We’re excited to share the topic and questions for this week’s #HITsm chat happening Friday, 4/14 at Noon ET (9 AM PT). This week’s chat will be hosted by Jess Clifton (@jslentzclifton), Sarah Bennight (@sarahbennight), and Steve Sisko (@shimcode) on the topic of “Healthcare Content Creation for the Audience Economy”.

The Healthcare IT Marketing and PR Conference (HITMC) took place last week and, as would be expected from an event largely attended by “marketing people,” social media lit up with content, insight, opinions and a bit of wackiness. Almost 2200 tweets were shared on Twitter alone during the three-day conference with the lion’s share of those tweets addressing the following topics:

  • Inspiration including leveraging influencer/champions, employees and the importance of passion
  • Content including case studies, personalization, repurposing, strategies, and use of experts as content creators.
  • Buyer Personas & Customer Journeys
  • Importance of Video and visual content
  • Innovation
  • Pitching media outlets and others to convey your content
  • Tips, tips and more tips

Based on the above and all the good information emanating from the HITMC event, this week’s #HITsm chat will explore “Healthcare Content Creation for the Audience Economy” via the following topics:

The Questions
T1: What are some of the ways content & messages can be made inspirational and humanized? #HITsm

T2: What are characteristics of a ‘good’ SME and how do you identify SME’s in your organization, tribe, circle of associates? #HITsm

T3: What are most effective types of ‘personalized content’ to share w/ a buyer & at what point in their journey? #HITsm

T4: What are some of the ways video can be used to market and support healthcare products/services?  #HITsm

T5: What’s not going to change in Healthcare in the next 10 years and how will content remain the same as it is today? #HITsm

Bonus: What are some of the best content marketing tips you learned at the HITMC? Or would like to share if you didn’t attend? #HITsm

Content, Insight, Opinions, Tips & Bits of Wackiness from #HITMC
For a curated list of tweets emanating from the HITMC event, check out this blog post.

Upcoming #HITsm Chat Schedule
4/21 – Innovation vs Incremental
Hosted by @Colin_Hung

4/28 – TBD

5/5 – TBD
Hosted by @IntelHealth

We look forward to learning from the #HITsm community! As always let us know if you have ideas for how to make #HITsm better.

If you’re searching for the latest #HITsm chat, you can always find the latest #HITsm chat and schedule of chats here.

23andMe Gets FDA Authorization for Consumer Genetic Health Risk Reports

Posted on I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

The big news about 23andMe’s FDA approval came out last week when I was holed up at a conference.

That’s right. 23andMe can now directly offer consumers a genetic health risk report that’s FDA approved. This is a big step for 23andMe when you consider that they’d previously gotten their hand slapped by the FDA.

23andMe got what’s called a de novo authorization from the FDA. This is something we’re likely to see more of and something that I’m sure many people aren’t familiar with. Here’s a description of what a de novo authorization is from the 23andMe announcement:

What does it mean to be granted a de novo authorization?
The Food and Drug Administration Modernization Act of 1997 (FDAMA) added the de novo classification option, which provides an alternate pathway to classify novel devices of low to moderate risk. The de novo process is used by the FDA to grant marketing authorization for devices that are new and unlike any other on the market. In addition de novo marketing authorization means that 23andMe met the FDA’s premarket requirements to demonstrate the following: accuracy, validity and user comprehension.

I’m glad that the FDA has created this new form of authorization for companies like 23andMe. This story also stands in stark contrast to other FDA related stories like Theranos. I’m sure that 23andMe would hate the comparison. However, there are some similarities. They both got slapped by the FDA. However, their response to the FDA’s notices was completely different. That’s why 23andMe seems to still be thriving and now have FDA approval. Theranos is floundering with reports that their founder now owes the company $25 million.

Needless to say, if you’re a healthcare startup, make sure you know the FDA regulations that apply to your startup.